Pretreatment maximal standardized uptake value of the primary tumor predicts outcome to radiotherapy in patients with pharyngeal cancer

Journal of Radiation Research

Volumn 53, Issue 3, 2012, Pages 462-468

  Lin, Shih Chieh ^a   Liao, Chih Ying ^e   Kao, Chia Hung ^a,b   Yen, Kuo Yang ^a,d   Yang, Shih Neng ^a,d   Wang, Yao Ching ^a   Liang, Ji An ^a,b   Chen, Shang Wen ^a,b,c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e Taichung Hospital   (Taiwan)

Author keywords

FDG PET CT; Pharyngeal carcinoma; Radiotherapy; SUV; Tumor volume

Indexed keywords

DISEASES; MULTIVARIANT ANALYSIS; PATIENT MONITORING; REGRESSION ANALYSIS; TUMORS;

CANCER PATIENTS; CLINICAL INFORMATION; FDG-PET-CT; HAZARD RATIO; OROPHARYNX; PHARYNGEAL CARCINOMA; PRE-TREATMENTS; STANDARDIZED UPTAKE VALUES; SUV; TUMOR VOLUMES;

RADIOTHERAPY;

EID: 84863429329     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.11174     Document Type: Article

References (25)

1. Studer G, et al (2007) Volumetric staging (VS) is superior to TNM and AJCC staging in predicting outcome of head and neck cancer treated with IMRT. Acta Oncol 46; 386-394.
2. Ohnishi K, et al (2011) Prediction of local failures with a combination of pretreatment tumor volume and apparent diffusion coefficient in patients treated with definitive radiotherapy for hypopharyngeal or oropharyngeal squamous cell carcinoma. J Radiat Res 52: 522-530.
3. Allal AS, et al (2004) Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2- [18F]fluoro-2-deoxy-D- glucose. Int J Radiat Oncol Biol Phys 59: 1295-1300.
4. Brun E, et al (2002) FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 24: 127-135.
5. Halfpenny W, et al (2002) A possible prognostic factor in head and neck cancer. Br J Cancer 86: 512-516.
6. Lee SW, et al (2008) Prediction of prognosis using standardized uptake value of 2-[(18)F]fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas. Radiother Oncol 87: 211-216.
7. Machtay M, et al (2009) Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer. Head Neck 31: 195-201.
8. Minn H, et al (1997) Prediction of survival with fluorine-18- fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med 38: 1907-1911.
9. Roh JL, et al (2007) 2-[18F]-Fluoro-2-deoxy-D-glucose pwsitron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx. Eur J Surg Oncol 33: 790-795.
10. Schwartz DL, et al (2004) FDG-PET prediction of head and neck squamous cell cancer outcomes. Arch Otolaryngol Head Neck Surg 130: 1361-1367.
11. Schinagl DAX, et al (2011) Can FDG PET predict radiation treatment outcome in head and neck cancer? Results of a prospective study. Eur J Nucl Med Mol Imaging 38: 1449-1458.
12. Chung MK, et al (2009) Metabolic tumor volume of [18F]- fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer. Clin Cancer Res 15: 5861-5868.
13. Seol YM, et al (2010) Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy. Acta Oncol 49: 201-208.
14. La TH, et al (2009) Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer. Int J Radiat Oncol Biol Phys 74: 1335-1341.
15. Soto DE, et al (2008) Correlation between pretreatment FDGPET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers. Radiother Oncol 89: 13-18.
16. Suzuki K, et al (2009) Value of fluorodeoxyglucose positron emission tomography before radiotherapy for head and neck cancer: does standardized value predict treatment outcome? Jpn J Radiol 27: 237-242.
17. Thorwarth D ,e ta l (2006) Combined uptake of [ 18F] FDG and [18F]FMIS0 correlates with radiation treatment outcome in head and neck cancer patients. Radiother Oncol 80: 151-156.
18. Vemon MR, et al (2008) Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma. Int J Radiat Oncol Biol Phys 70: 678-684.
19. Kao CH, et al (2010) 18F-FDG PET/CT-based gross tumor volume definition for radiotherapy in head and neck cancer: a correlation study between suitable uptake value threshold and tumor parameters. Radiat Oncol 5: 76.
20. Chen SW, et al (2009) Prognostic impact of tumor volume in patients with stage III-IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy. Head Neck 31: 709-716.
21. Adelstein DJ, et al (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21: 92-98.
22. Therasse P, et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216.
23. Minn H, et al (1995) In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and Lmethionine in squamous-cell carcinoma of the head and neck. J Nucl Med 36: 252-258.
24. Clavo AC, Brown RS and Wahl RL (1995) Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med 36: 1625-1632.
25. Furuta M, et al (1997) Rapid rise in FDG uptake in an irradiated human tumour xenograft. Eur J Nucl Med 24: 435-438.